Literature DB >> 15074571

Incidence of interstitial lung diseases in the south of Spain 1998-2000: the RENIA study.

José Luis López-Campos1, Eulogio Rodríguez-Becerra.   

Abstract

UNLABELLED: This study aims to describe the distribution of interstitial lung diseases (ILD) in the South of Spain.
METHODS: A prospective multicentre population-based registry was established in nine provinces in the south of Spain with a population of 6,848,243 during a 3-year period (1998-2000). The number of participant physicians was 36 among 29 public hospitals. The number of diagnoses recorded was 66, divided in eight categories and coded according to ICD-9. A consensus document was elaborated for the classification of diseases and their diagnostic criteria. The number of cases declared was analysed each 3 months and communicated to each one of the participants.
RESULTS: There were 744 cases of them registered with an annual incidence of 3.62 cases/ 100,000. 40.1% of diagnoses were biopsy confirmed. Men had a slightly higher incidence (4.18 cases/ 100,000/year) than women (3.07 cases/100,000/year). The most frequent diseases found were: idiopathic interstitial pneumonias (38.58%), ILD associated to systemic diseases (20.97%), and Sarcoidosis (11.69%). According to province distribution, most of the cases were grouped in an area between the provinces of Seville and Cordoba, which comprised more than 50% of cases.
CONCLUSIONS: The study of the incidence of ILD depicts an intermediate situation from previous studies on the incidence and distribution of this group of diseases.

Entities:  

Mesh:

Year:  2004        PMID: 15074571     DOI: 10.1023/b:ejep.0000017660.18541.83

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  18 in total

Review 1.  American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS).

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2000-02       Impact factor: 21.405

Review 2.  Hypersensitivity pneumonitis.

Authors:  J N Fink
Journal:  Clin Chest Med       Date:  1992-06       Impact factor: 2.878

Review 3.  Coal workers' pneumoconiosis.

Authors:  N L Lapp; J E Parker
Journal:  Clin Chest Med       Date:  1992-06       Impact factor: 2.878

Review 4.  Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification.

Authors:  A L Katzenstein; J L Myers
Journal:  Am J Respir Crit Care Med       Date:  1998-04       Impact factor: 21.405

5.  World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects.

Authors: 
Journal:  JAMA       Date:  1997-03-19       Impact factor: 56.272

6.  Drugs that may injure the respiratory system.

Authors:  P Foucher; M Biour; J P Blayac; P Godard; C Sgro; M Kuhn; J M Vergnon; D Vervloet; P Pfitzenmeyer; M Ollagnier; C Mayaud; P Camus
Journal:  Eur Respir J       Date:  1997-02       Impact factor: 16.671

7.  The epidemiology of interstitial lung diseases.

Authors:  D B Coultas; R E Zumwalt; W C Black; R E Sobonya
Journal:  Am J Respir Crit Care Med       Date:  1994-10       Impact factor: 21.405

Review 8.  Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1999-08       Impact factor: 21.405

9.  [Analysis of admissions for chronic obstructive pulmonary disease in Andalusia in 2000].

Authors:  J L López-Campos Bodineau; J Fernández Guerra; A Lara Blanquer; E Perea-Milla López; L Moreno; J J Cebrián Gallardo; J M García Jiménez
Journal:  Arch Bronconeumol       Date:  2002-10       Impact factor: 4.872

Review 10.  Bronchiolitis obliterans organizing pneumonia: definition and clinical features.

Authors:  G R Epler
Journal:  Chest       Date:  1992-07       Impact factor: 9.410

View more
  17 in total

Review 1.  Disease Burden and Variability in Sarcoidosis.

Authors:  Alicia K Gerke; Marc A Judson; Yvette C Cozier; Daniel A Culver; Laura L Koth
Journal:  Ann Am Thorac Soc       Date:  2017-12

Review 2.  Type 2 macrophages and Th2 CD4+ cells in interstitial lung diseases (ILDs): an overview.

Authors:  Neftali Partida-Zavala; Marco Antonio Ponce-Gallegos; Ivette Buendía-Roldán; Ramcés Falfán-Valencia
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

3.  The incidence of interstitial lung disease 1995-2005: a Danish nationwide population-based study.

Authors:  Jette B Kornum; Steffen Christensen; Miriam Grijota; Lars Pedersen; Pia Wogelius; Annette Beiderbeck; Henrik Toft Sørensen
Journal:  BMC Pulm Med       Date:  2008-11-04       Impact factor: 3.317

4.  Interstitial lung disease (ILD) in India: Insights and lessons from the prospective, landmark ILD-India registry.

Authors:  Ganesh Raghu; Sanjeev Mehta
Journal:  Lung India       Date:  2016 Nov-Dec

5.  Spectrum of interstitial lung diseases at a tertiary center in a developing country: A study of 803 subjects.

Authors:  Sahajal Dhooria; Ritesh Agarwal; Inderpaul Singh Sehgal; Kuruswamy Thurai Prasad; Mandeep Garg; Amanjit Bal; Ashutosh Nath Aggarwal; Digambar Behera
Journal:  PLoS One       Date:  2018-02-08       Impact factor: 3.240

6.  Characteristics and outcomes of patients hospitalized with interstitial lung diseases in Spain, 2014 to 2015.

Authors:  Fernando Pedraza-Serrano; Rodrigo Jiménez-García; Ana López-de-Andrés; Valentin Hernández-Barrera; Gema Sánchez-Muñoz; Luis Puente-Maestu; Javier de-Miguel-Díez
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

7.  Value of immune factors for monitoring risk of lung cancer in patients with interstitial lung disease.

Authors:  Ning Li; Haisheng Hu; Ge Wu; Baoqing Sun
Journal:  J Int Med Res       Date:  2019-07-01       Impact factor: 1.671

8.  Incidence of interstitial pneumonitis among breast cancer patients: a 10-year Danish population-based cohort study.

Authors:  S Christensen; L Pedersen; M Grijota; J B Kornum; A Beiderbeck; H T Sørensen
Journal:  Br J Cancer       Date:  2008-05-27       Impact factor: 7.640

9.  Exploring Clinical and Epidemiological Characteristics of Interstitial Lung Diseases: Rationale, Aims, and Design of a Nationwide Prospective Registry--The EXCITING-ILD Registry.

Authors:  Michael Kreuter; Felix J F Herth; Margarethe Wacker; Reiner Leidl; Andreas Hellmann; Michael Pfeifer; Jürgen Behr; Sabine Witt; Dagmar Kauschka; Marcus Mall; Andreas Günther; Philipp Markart
Journal:  Biomed Res Int       Date:  2015-11-10       Impact factor: 3.411

10.  Demographic and clinical predictors of progression and mortality in connective tissue disease-associated interstitial lung disease: a retrospective cohort study.

Authors:  Chrystal Chan; Christopher J Ryerson; James V Dunne; Pearce G Wilcox
Journal:  BMC Pulm Med       Date:  2019-10-31       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.